HAE (Haemonetics) Quarterly Revenue Growth

Graphic logo of haemonetics.com (HAE)

Stable cash flows for Haemonetics Corporation (HAE) are secured by patent protection for hemodialysis systems and strict FDA oversight. The current quarterly revenue growth rate confirms these positions, with the parameter value equal to 9.50. High loyalty among the staff of engineers and scientists supports innovation, while the consumables sales model guarantees excellent business scalability within the medtech sector.

HAE (Haemonetics Corp) Quarterly Sales Growth history from 07/04/2022 to 11/20/2026

Haemonetics Corp. - analytical breakdowns and key metrics (HAE)

- stock price and consensus target price:
- business market valuation indicators:
General company analysis:Haemonetics Corp (HAE)
Mass-produced product of Haemonetics Corp

The development of the NexSys R&D pipeline and software updates for donor centers are directly reflected in the quarterly sales growth dynamics of Haemonetics Corporation (HAE). This indicator measures the rate of revenue change between periods to identify artificial manipulations of sales volumes; while sharp spikes in the metric signal the risk of a subsequent deep drawdown, stagnation may mask a critical decline in business liquidity.

Main competitors

DexCom Inc - Quarterly Revenue Growth|PEN (Penumbra, Inc.) - Sales Growth QoQ|NOVT: Quarterly Revenue Growth|Sales Growth QoQ INSP|PRCT (Procept) - Quarterly Revenue Growth|CONMED Corp. (CNMD) - Quarterly Sales Growth Rate|Quarterly Revenue Growth PLSE|Quarterly Sales Growth InMode Ltd. INMD|Revenue Growth QoQ Picard Medical PMI|Quarterly Revenue Growth Surmodics Inc SRDX|SENS - Revenue Growth QoQ|NPCE: Revenue Growth QoQ|TCMD (Tactile Systems Technology Inc.) - Quarterly Sales Growth|Sanuwave Health Inc - Quarterly Revenue Increase|Quarterly Sales Growth OM|Quarterly Revenue Growth Rate smartvest.com ELMD|Revenue Growth QoQ LENSAR Inc. (LNSR)|AVITA Medical, Inc. (RCEL) - Revenue Change vs Previous Quarter|Profound Medical Corp - Quarterly Sales Growth|Quarterly Revenue Growth Baird Medical Corp BDMD|EDAP TMS SA - Quarterly Revenue Growth|Quarterly Sales Growth Rate Apyx Medical Corporation APYX|IceCure Medical (ICCM) - Revenue Growth QoQ|Revenue Dynamics QoQ LUNG (Pulmonx Corp.)|Revenue Growth QoQ telabio.com|Quarterly Sales Growth Cytosorbents (CTSO)|Quarterly Revenue Growth SRTS|ZYXI - Quarterly Revenue Growth Rate|Revenue Growth QoQ electrocore.com ECOR|RBOT: Sales Growth QoQ|IINN: Quarterly Sales Growth|Quarterly Sales Growth Rate SeaStar Medical Holding ICU|IRIX: Quarterly Revenue Growth|INBS - Quarterly Sales Growth Rate|XAIR (Beyond Air Inc) - Quarterly Revenue Growth|PFSA: Quarterly Revenue Increase|Revenue Growth QoQ STRATA Skin Sciences Inc. (SSKN)|Quarterly Revenue Growth GlucoTrack, Inc. (GCTK)|Revenue Growth QoQ nanovibronix.com NAOV|Quarterly Revenue Growth Venus Concept Inc VERO|NUWE - Revenue Growth QoQ|AEMD: Revenue Growth QoQ|ASXC (Asensus Surgical) - Quarterly Sales Growth|Quarterly Revenue Growth Rate avinger.com (AVGR)|Quarterly Sales Growth BSGM|CUTR: Quarterly Revenue Increase|Revenue Growth QoQ Know Labs Corporation (KNW)|NARI - Quarterly Revenue Growth Rate|Revenue Growth QoQ Nevro Corp. NVRO|ReShape Lifesciences Inc - Revenue Growth QoQ|SILK: Quarterly Sales Growth